A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
Titel:
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
Auteur:
Pant, S. Saleh, M. Bendell, J. Infante, J.R. Jones, S. Kurkjian, C.D. Moore, K.M. Kazakin, J. Abbadessa, G. Wang, Y. Chen, Y. Schwartz, B. Camacho, L.H.